Literature Review

Low LDL cholesterol may increase women’s risk of hemorrhagic stroke


 

FROM NEUROLOGY

Mechanism of increased risk unclear

The researchers do not yet know how low triglyceride and LDL cholesterol levels increase the risk of hemorrhagic stroke. One hypothesis is that low cholesterol promotes necrosis of the arterial medial layer’s smooth muscle cells. This impaired endothelium might be more susceptible to microaneurysms, which are common in patients with ICH, said the researchers.

The prospective design and the large sample size were two of the study’s strengths, but the study had important weaknesses as well, the researchers wrote. For example, few women were premenopausal at baseline, so the investigators could not evaluate whether menopausal status modifies the association between lipid levels and risk of hemorrhagic stroke. In addition, lipid levels were measured only at baseline, which prevented an analysis of whether change in lipid levels over time modifies the risk of hemorrhagic stroke.

Dr. Rist reported receiving a grant from the National Institutes of Health.

SOURCE: Rist PM et al. Neurology. 2019 April 10. doi: 10.1212/WNL.0000000000007454.

Pages

Recommended Reading

Most U.S. tPA-eligible stroke patients now get treated within an hour
MDedge Internal Medicine
Vaccination and antiviral treatment do not affect stroke risk following shingles
MDedge Internal Medicine
Hormone therapy in transgender individuals may up risk of CV events
MDedge Internal Medicine
Noncardiac surgery has 7% covert stroke rate in elderly
MDedge Internal Medicine
Glyceryl trinitrate does not improve outcomes of ischemic stroke
MDedge Internal Medicine
Eisenmenger syndrome is a minefield for unwary physicians
MDedge Internal Medicine
MI, strokes spike during 30 days after cancer diagnosis
MDedge Internal Medicine
Premature death from heart disease hits Asian subgroups hard
MDedge Internal Medicine
Intensive blood pressure lowering may not reduce risk of recurrent stroke
MDedge Internal Medicine
Ticagrelor reversal agent looks promising
MDedge Internal Medicine